CC-115 is a dual inhibitor of DNA-dependent protein kinase and mammalian target of rapamycin, with potential antineoplastic activity.
For research use only. We do not sell to patients.
Name | CC-115 |
---|---|
Iupac Chemical Name | 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one |
Synonyms | CC115 ; CC 115 |
Molecular Formula | C16H16N8O |
Molecular Weight | 336.14 |
Smile | O=C1CNC2=NC=C(C3=CC=C(C4=NC=NN4)N=C3C)N=C2N1CC |
InChiKey | GMYLVKUGJMYTFB-UHFFFAOYSA-N |
InChi | InChI=1S/C16H16N8O/c1-3-24-13(25)7-18-15-16(24)22-12(6-17-15)10-4-5-11(21-9(10)2)14-19-8-20-23-14/h4-6,8H,3,7H2,1-2H3,(H,17,18)(H,19,20,23) |
CAS Number | 1228013-15-7 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Solid powder |
---|---|
Purity | 98% |
Storage | -20 ºC for 3 years |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |